X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
Thumbnail
AbbVie's (ABBV) Skyrizi becomes the first specific IL-23 inhibitor to get approval for Crohn's disease in the European Union. [Read More]
Save As
Preview
Preview